Category Archives: Patent Eligibility (101)

Federal Circuit denies Athena’s petition for rehearing of finding that its claims relating to a correlation between antibodies to a protein (“MuSK”) and neurological disorders are invalid under § 101.

Athena Diagnostics, Inc. et al. v. Mayo Collaborative Services, LLC Docket No. 2017-2508 NEWMAN (D), LOURIE, STOLL February 6, 2019 (Petition for rehearing denied July 3, 2019) Update (July 3, 2019): Athena’s petition for rehearing regarding the invalidation under § … Continue reading

Posted in Patent Eligibility (101), Patentability | Leave a comment

DC’s motion to dismiss and attorney fees award vacated and remanded as Cellspin’s amended complaint alleged an inventive concept and issued patents are presumed valid and patent eligible

Cellspin Soft, Inc. v. Fitbit, Inc. et al. (Moov, Nike, Fossil, Canon, GoPro, Panasonic, and JKI); Docket Nos. 2018-1817-26, -2178-84 (June 25, 2019) Brief Summary:  DC grant of Fitbit’s motion to dismiss for patent ineligibility under section 101 and the … Continue reading

Posted in Patent Eligibility (101), Patentability, Software | Leave a comment